Dr Cheong May Anne

​Dr Cheong May Anne is a Consultant in the Department of Haematology, Singapore General Hospital. She was awarded the NUS Undergraduate (Merit) Scholarship to read Medicine at the National University of Singapore and graduated in 2012. She completed her Internal Medicine training at Singhealth in 2017 and also served as the Internal Medicine Chief Resident. She completed specialist training in Haematology at Singhealth in 2020 and obtained her FRCPath (Haematology) in 2019. Dr Cheong has a special interest in the treatment of bleeding and clotting disorders. To complement her clinical work, Dr Cheong is also involved in many healthcare innovation initiatives and started the Singhealth Hackathon series to support ground up projects.

• ​Lead, Apps Development Interest Group Medicine ACP, Singhealth
  
• Core Faculty, Singhealth Internal Medicine Residency
  
• Clinical Tutor – Yong Loo Lin School of Medicine, NUS
  
• Clinical Instructor – Duke-NUS Medical School
  
• Executive Committee Member, Singapore Society of Haematology

• ​Singhealth Health Quality Service HERO Award 2021 Outstanding Resident Award (Haematology) 2020
• Outstanding Chief Resident Award 2019
• Service Quality Award (Silver) 2018
• Outstanding Resident Award (Internal Medicine) 2015, 2016, 2017
  

• ​Tan JY, Tan CW, Wong WH, Cheong MA, Lee LH, Kalimuddin S, et al. Post-hospitalization venous thromboembolism in COVID-19 patients: Evidence against routine post-hospitalization prophylactic anticoagulation. Int J Lab Hematol [Internet]. 2021 Jun 19; Available from: http://www.ncbi.nlm.nih.gov/pubmed/34146452
  
• Tan CW, Tan JY, Wong WH, Cheong MA, Ng IM, Conceicao EP, et al. Clinical and laboratory features of hypercoagulability in COVID-19 and other respiratory viral infections amongst predominantly younger adults with few comorbidities. Sci Rep [Internet]. 2021;11(1):1793. Available from: http://www.ncbi.nlm.nih.gov/pubmed/33469056
  
• Maung AC, Cheong MA, Chua YY, Gardner DS-L. When a storm showers the blood clots: a case of thyroid storm with systemic thromboembolism. Endocrinol diabetes Metab case reports. 2021 Jan;2021.
  
• Cheong MA, Chee YL, Ng HJ, Jen WY. Keeping the bloodline of haematology medical education flowing during a pandemic. Int J Lab Hematol. 2020;42(5):e196-e198.
  
• Lim CC, Lwin KZL, Cheong MA, Kanagasabapathy K, Nagarajan C, Loh A. An unusual cause of renal tubular dysfunction in multiple myeloma. Vol. 52, International urology and nephrology. Netherlands; 2020. p. 1603–5.
  
• Lam Yi H, Than H, Sng C, Cheong MA, Chuah C, Xiang W. Lysosome Inhibition by Mefloquine Preferentially Enhances the Cytotoxic Effects of Tyrosine Kinase Inhibitors in Blast Phase Chronic Myeloid Leukemia. Transl Oncol. 2019 Sep;12(9):1221–8.
  
• Cheong MA, Tan CW, Linn YC, Hwang WYK. Central Pontine Myelinolysis Associated with Cyclosporine in a Patient with NK Cell Leukemia after Hematopoietic Stem Cell Transplantation. Int J Stem Cell Res Transplant 04(1), 142- 145.
  
• Lim SH, Aw SJ, Cheong MA, Chew J, Ler AC, Yong LP, et al. A randomised control trial to compare retention rates of two cardiopulmonary resuscitation instruction methods in the novice. Resuscitation. 2016 Jun;103:82–7.
  
• Tay SK, Cheong MA. Evidence for ethnic and environmental contributions to frequency of ovarian clear cell carcinoma. Aust N Z J Obstet Gynaecol. 2014 Jun;54(3):225–30.
  
• MA Cheong, C Tay. Application of legal principles and medical ethics: multifetal pregnancy and fetal reduction. SMJ 2014; 55(6): 298-301